JY231 Injection in the Treatment of Relapsed or Refractory B-cell Lymphoma
NCT06045585
·
clinicaltrials.gov ↗
EARLY_PHASE1
Phase
UNKNOWN
Status
20
Enrollment
OTHER
Sponsor class
Conditions
Relapsed or Refractory B-cell Lymphoma
Interventions
BIOLOGICAL:
infusion of JY231 injection
Sponsor
Guangdong Second Provincial General Hospital